Lingke
X

 

      +86 0571-87711179

ychen1@lynkpharma.com


lynk Pharmaceutical (Hangzhou) Co., Ltd.    |    浙ICP备18056091号-1   |   Powered by www.300.cn    |   Manager

CONTACT US

website

Search

291 Fucheng Road, Bldg 5-402, Jianggan,
Hangzhou, Zhejiang 310018, China

 

Hangzhou

LYNK  PHARMACEUTICALS

FOCUSED ON THE CURE

Lynk Pharmaceuticals was founded by veteran drug hunters from Pfizer, Merck and Johnson

& Johnson with more than 7 decades of rich experiences in drug discovery collectively. Driven

by a higher purpose, Lynk Pharmaceuticals aims at growing into a market leader for developing
innovative therapies to address unmet medical needs in Asian Pacific and with a global reach.
......

NEWS CENTER

 

Incorporated

 

About 

2018

1800

40

Facilities

 

Employees

About 

 people

Angel Round Financing

63

million

m

2

Lynk Pharmaceuticals enters exclusive licensing agreements develop RAS inhibitors with a novel MOA
$!info.title
HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals is pleased to announce exclusive licensing agreements with Kobe  University and RIKEN Research Institute to develop RAS inhibitors with a novel MOA.
2020-07-28 11:51
Lynk Pharmaceuticals successfully out-licensed a preclinical candidate
$!info.title
Lynk Pharmaceuticals successfully out-licensed a preclinical candidate to a US company in April, 2020. Details will be announced at a later date.
2020-07-19 16:59
On May 8, 2020, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, and Lynk Pharmaceuticals jointly founded IBMC-Lynk New Drug Discovery Center.
$!info.title
On May 8, 2020, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, and Lynk Pharmaceuticals jointly founded IBMC-Lynk New Drug Discovery Center.
2020-07-19 16:57